Clinical Trial Update: Operator and Patient Acceptance of Radiofrequency Cautery of the Biopsy Track During Percutaneous Liver, Kidney or Spleen Biopsy Procedures. [NA]

View source ↗

Summary

The clinical trial NCT05790109 evaluating radiofrequency cautery of the biopsy track during percutaneous liver, kidney, or spleen biopsies has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bleeding Disorders
• Kidney Diseases
• Liver Diseases
• Spleen Disorders

Snippet

Sponsor: Brigham and Women's Hospital | Conditions: Bleeding Disorder, Spleen Lesion | NA | Status: WITHDRAWN